TrialFind
Search
About
Saved trials
Back to results
Withdrawn
Phase 2
Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
NCT02667496
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Investigational Site Number 840001
Houston, Texas, United States
View on ClinicalTrials.gov
Official details
Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease — TrialFind